<SEC-DOCUMENT>0001209191-20-034566.txt : 20200604
<SEC-HEADER>0001209191-20-034566.hdr.sgml : 20200604
<ACCEPTANCE-DATETIME>20200604192634
ACCESSION NUMBER:		0001209191-20-034566
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20200604
FILED AS OF DATE:		20200604
DATE AS OF CHANGE:		20200604

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			COOPER GRAHAM K
		CENTRAL INDEX KEY:			0001396943

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39306
		FILM NUMBER:		20944120

	MAIL ADDRESS:	
		STREET 1:		C/O RECEPTOS, INC.
		STREET 2:		10835 ROAD TO THE CURE, SUITE 205
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Applied Molecular Transport Inc.
		CENTRAL INDEX KEY:			0001801777
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				814481426
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		1 TOWER PLACE, SUITE 850
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650-392-0420

	MAIL ADDRESS:	
		STREET 1:		1 TOWER PLACE, SUITE 850
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Applied Molecular Transport LLC
		DATE OF NAME CHANGE:	20200130
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>doc3.xml
<DESCRIPTION>FORM 3 SUBMISSION
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2020-06-04</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001801777</issuerCik>
        <issuerName>Applied Molecular Transport Inc.</issuerName>
        <issuerTradingSymbol>AMTI</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001396943</rptOwnerCik>
            <rptOwnerName>COOPER GRAHAM K</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O APPLIED MOLECULAR TRANSPORT INC.</rptOwnerStreet1>
            <rptOwnerStreet2>1 TOWER PLACE, SUITE 850</rptOwnerStreet2>
            <rptOwnerCity>SOUTH SAN FRANCISCO</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>94080</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Stock Option (Right to Buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>4.61</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2020-02-05</value>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <value>2030-03-06</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>75000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">1/24th of the shares subject to the option granted on March 3, 2020 became vested and exercisable on the Exercisable Date set forth above and 1/24th of the shares subject to the option shall vest monthly thereafter, provided that reporting person remains a service provider to the issuer on each such vest date.</footnote>
    </footnotes>

    <remarks>Date set forth above represents the effective date of the issuer's initial public offering.</remarks>

    <ownerSignature>
        <signatureName>/s/Brandon Hants Attorney-in-Fact for Graham Cooper</signatureName>
        <signatureDate>2020-06-04</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.3_920189
<SEQUENCE>2
<FILENAME>poa.txt
<DESCRIPTION>POA DOCUMENT
<TEXT>
POWER OF ATTORNEY

The undersigned, as a Section 16 reporting person of Applied Molecular Transport
Inc. (the "Company"), hereby constitutes and appoints Tahir Mahmood, Shawn Cross
and Brandon Hants, and each of them, as the undersigned's true and lawful
attorney-in-fact to:

1.	complete and execute Forms 3, 4 and 5 and other forms and all amendments
thereto as such attorney-in-fact shall in his discretion determine to be
required or advisable pursuant to Section 16 of the Securities Exchange Act of
1934 (as amended) and the rules and regulations promulgated thereunder, or any
successor laws and regulations, as a consequence of the undersigned's ownership,
acquisition or disposition of securities of the Company; and

2.	do all acts necessary in order to file such forms with the SEC, any
securities exchange or national association, the Company and such other person
or agency as the attorneys-in-fact shall deem appropriate.

The undersigned hereby ratifies and confirms all that said attorneys-in-fact and
agents shall do or cause to be done by virtue hereof.  The undersigned
acknowledges that the foregoing attorneys-in-fact, in serving in such capacity
at the request of the undersigned, are not assuming, nor is the Company
assuming, any of the undersigned's responsibilities to comply with Section 16 of
the Securities Exchange Act of 1934 (as amended).

This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
Company and the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 29th day of May, 2020.


Signature:  /s/Graham Cooper

Print Name:  Graham Cooper

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
